BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Unno M, Katayose Y, Rikiyama T, Yoshida H, Yamamoto K, Morikawa T, Hayashi H, Motoi F, Egawa S. Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2010;17:463-469. [PMID: 19941010 DOI: 10.1007/s00534-009-0206-3] [Cited by in Crossref: 69] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Franken LC, Schreuder AM, Roos E, van Dieren S, Busch OR, Besselink MG, van Gulik TM. Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis. Surgery. 2019;165:918-928. [PMID: 30871811 DOI: 10.1016/j.surg.2019.01.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
2 Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014;399:693-705. [PMID: 24841192 DOI: 10.1007/s00423-014-1210-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
3 Wang Y, Duan B, Yan L, Shen C, Wu B, Luo J, Shen F, Zhao G. Long-term outcome after surgical resection for cholangiocarcinoma and prognostic index value. Surgeon 2016;14:38-43. [PMID: 25263386 DOI: 10.1016/j.surge.2014.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
4 Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol 2011; 2(2): 94-107 [PMID: 21603318 DOI: 10.5306/wjco.v2.i2.94] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
5 Hoffmann K, Luible S, Goeppert B, Weiss K, Hinz U, Büchler MW, Schemmer P. Impact of portal vein resection on oncologic long-term outcome in patients with hilar cholangiocarcinoma. Surgery 2015;158:1252-60. [DOI: 10.1016/j.surg.2015.04.032] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
6 Sano T, Shimizu Y, Senda Y, Kinoshita T, Nimura Y. Assessing resectability in cholangiocarcinoma. Hepat Oncol 2014;1:39-51. [PMID: 30190940 DOI: 10.2217/hep.13.6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
7 Hibi T, Shinoda M, Itano O, Kitagawa Y. Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine. Organogenesis 2014;10:241-9. [PMID: 24836922 DOI: 10.4161/org.29245] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Blechacz B. Cholangiocarcinoma: Current Knowledge and New Developments. Gut Liver. 2017;11:13-26. [PMID: 27928095 DOI: 10.5009/gnl15568] [Cited by in Crossref: 160] [Cited by in F6Publishing: 150] [Article Influence: 32.0] [Reference Citation Analysis]
9 Mitsuura C, Okabe H, Yamashita YI, Itoyama R, Yamao T, Umezaki N, Miyata T, Higashi T, Yamamura K, Nakagawa S, Imai K, Hayashi H, Chikamoto A, Baba H. A case of chest wall recurrence of hilar cholangiocarcinoma 10 years after R1 surgery with positive ductal margin of carcinoma in situ. Int Cancer Conf J 2020;9:77-81. [PMID: 32257758 DOI: 10.1007/s13691-020-00400-y] [Reference Citation Analysis]
10 Reddy SK, Barbas AS, Turley RS, Steel JL, Tsung A, Marsh JW, Geller DA, Clary BM. A standard definition of major hepatectomy: resection of four or more liver segments. HPB (Oxford) 2011;13:494-502. [PMID: 21689233 DOI: 10.1111/j.1477-2574.2011.00330.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 102] [Article Influence: 10.8] [Reference Citation Analysis]
11 Poruk KE, Pawlik TM, Weiss MJ. Perioperative Management of Hilar Cholangiocarcinoma. J Gastrointest Surg 2015;19:1889-99. [PMID: 26022776 DOI: 10.1007/s11605-015-2854-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
12 Zhang W, Yan LN. Perihilar cholangiocarcinoma: Current therapy. World J Gastrointest Pathophysiol 2014; 5(3): 344-354 [PMID: 25133034 DOI: 10.4291/wjgp.v5.i3.344] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
13 Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014;3:18-34. [PMID: 24696835 DOI: 10.3978/j.issn.2304-3881.2014.02.05] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
14 Mori A, Masuda K, Ohtsuka H, Shijo M, Ariake K, Fukase K, Sakata N, Mizuma M, Morikawa T, Hayashi H, Nakagawa K, Motoi F, Naitoh T, Fujishima F, Unno M. FBXW7 modulates malignant potential and cisplatin-induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1. Cancer Sci 2018;109:3883-95. [PMID: 30302867 DOI: 10.1111/cas.13829] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
15 Seki T, Igami T, Ebata T, Yokoyama Y, Sugawara G, Suzumura K, Nagino M. Six-year survival following left hepatic trisectionectomy with simultaneous resection of the portal vein and right hepatic artery for advanced perihilar cholangiocarcinoma without lymph node metastases: report of a case. Clin J Gastroenterol 2012;5:327-31. [PMID: 26181070 DOI: 10.1007/s12328-012-0322-5] [Reference Citation Analysis]
16 Ohtsubo I, Ajiki T, Hori Y, Murakami S, Shimizu K, Itoh T, Shimizu M, Fukumoto T, Ku Y. Distinctive expression of CD133 between intraductal papillary neoplasms of the bile duct and bile duct adenocarcinomas: CD133 expression in IPNB. Hepatology Research 2012;42:574-82. [DOI: 10.1111/j.1872-034x.2011.00954.x] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
17 Kambakamba P, Deoliveira ML. Perihilar cholangiocarcinoma: paradigms of surgical management. The American Journal of Surgery 2014;208:563-70. [DOI: 10.1016/j.amjsurg.2014.05.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
18 Hartog H, Ijzermans JN, van Gulik TM, Koerkamp BG. Resection of Perihilar Cholangiocarcinoma. Surgical Clinics of North America 2016;96:247-67. [DOI: 10.1016/j.suc.2015.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
19 Ratti F, Cipriani F, Piozzi G, Catena M, Paganelli M, Aldrighetti L. Comparative Analysis of Left- Versus Right-sided Resection in Klatskin Tumor Surgery: can Lesion Side be Considered a Prognostic Factor? J Gastrointest Surg 2015;19:1324-33. [DOI: 10.1007/s11605-015-2840-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
20 Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, Sakabe R, Ohge H, Sueda T. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 2011;18:651-8. [PMID: 20945107 DOI: 10.1245/s10434-010-1325-4] [Cited by in Crossref: 143] [Cited by in F6Publishing: 128] [Article Influence: 11.9] [Reference Citation Analysis]
21 Fisher AV, Ronnekleiv-kelly SM. Surgical Management of Hilar Cholangiocarcinoma. Curr Surg Rep 2018;6. [DOI: 10.1007/s40137-018-0210-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Han IW, Jang JY, Lee KB, Kang MJ, Kwon W, Park JW, Chang YR, Kim SW. Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin. HPB (Oxford) 2014;16:575-81. [PMID: 24308425 DOI: 10.1111/hpb.12193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
23 Wu XP, Ni JM, Zhang ZY, Lu FQ, Li B, Jin HH, Dai T. Preoperative Evaluation of Malignant Perihilar Biliary Obstruction: Negative-Contrast CT Cholangiopancreatography and CT Angiography Versus MRCP and MR Angiography. AJR Am J Roentgenol 2015;205:780-8. [PMID: 26397326 DOI: 10.2214/AJR.14.13983] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Miyazaki M, Yoshitomi H, Miyakawa S, Uesaka K, Unno M, Endo I, Ota T, Ohtsuka M, Kinoshita H, Shimada K, Shimizu H, Tabata M, Chijiiwa K, Nagino M, Hirano S, Wakai T, Wada K, Isayama H, Okusaka T, Tsuyuguchi T, Fujita N, Furuse J, Yamao K, Murakami K, Yamazaki H, Kijima H, Nakanuma Y, Yoshida M, Takayashiki T, Takada T. Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepatobiliary Pancreat Sci. 2015;22:249-273. [PMID: 25787274 DOI: 10.1002/jhbp.233] [Cited by in Crossref: 119] [Cited by in F6Publishing: 97] [Article Influence: 17.0] [Reference Citation Analysis]
25 Seehofer D, Kamphues C, Neuhaus P. [Resection of Klatskin tumors]. Chirurg 2012;83:221-8. [PMID: 22406679 DOI: 10.1007/s00104-011-2177-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
26 Yokoyama Y, Nagino M, Ebata T. Importance of "muscle" and "intestine" training before major HPB surgery: A review. J Hepatobiliary Pancreat Sci 2021;28:545-55. [PMID: 33058524 DOI: 10.1002/jhbp.835] [Reference Citation Analysis]
27 Geers J, Jaekers J, Topal H, Aerts R, Vandoren C, Vanden Boer G, Topal B. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma. World J Surg Oncol 2020;18:286. [PMID: 33143698 DOI: 10.1186/s12957-020-02060-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Ding G, Yang Y, Cao L, Chen W, Wu Z, Jiang G. A modified Jarnagin-Blumgart classification better predicts survival for resectable hilar cholangiocarcinoma. World J Surg Oncol. 2015;13:99. [PMID: 25889726 DOI: 10.1186/s12957-015-0526-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
29 Kimura N, Young AL, Toyoki Y, Wyatt JI, Toogood GJ, Hidalgo E, Prasad KR, Kudo D, Ishido K, Hakamada K, Lodge JPA. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors. Surgery. 2017;162:500-514. [PMID: 28551378 DOI: 10.1016/j.surg.2017.03.017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
30 Natsume S, Ebata T, Yokoyama Y, Igami T, Sugawara G, Shimoyama Y, Nagino M. Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy. Ann Surg. 2012;255:754-762. [PMID: 22367444 DOI: 10.1097/sla.0b013e31824a8d82] [Cited by in Crossref: 67] [Cited by in F6Publishing: 27] [Article Influence: 6.7] [Reference Citation Analysis]
31 Zharikov YO, Kovalenko YA, Czhao AV. [Biomolecular prognostic factors in Klatskin tumor]. Khirurgiia (Mosk) 2016;:82-5. [PMID: 27447008 DOI: 10.17116/hirurgia2016582-85] [Reference Citation Analysis]
32 Lindnér P, Rizell M, Hafström L. The impact of changed strategies for patients with cholangiocarcinoma in this millenium. HPB Surg 2015;2015:736049. [PMID: 25788760 DOI: 10.1155/2015/736049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
33 Cho A, Yamamoto H, Kainuma O, Muto Y, Yanagibashi H, Tonooka T, Masuda T. Laparoscopy in the management of hilar cholangiocarcinoma. World J Gastroenterol 2014; 20(41): 15153-15157 [PMID: 25386064 DOI: 10.3748/wjg.v20.i41.15153] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
34 Promsorn J, Soontrapa W, Somsap K, Chamadol N, Limpawattana P, Harisinghani M. Evaluation of the diagnostic performance of apparent diffusion coefficient (ADC) values on diffusion-weighted magnetic resonance imaging (DWI) in differentiating between benign and metastatic lymph nodes in cases of cholangiocarcinoma. Abdom Radiol (NY). 2019;44:473-481. [PMID: 30151713 DOI: 10.1007/s00261-018-1742-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
35 Otsuka S, Ebata T, Yokoyama Y, Mizuno T, Tsukahara T, Shimoyama Y, Ando M, Nagino M. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma. British Journal of Surgery 2019;106:774-82. [DOI: 10.1002/bjs.11125] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
36 Ariake K, Unno M, Yoshida H, Kubo S, Horiguchi A, Yamaue H, Yamamoto M. Risk factors and characteristics of young patients with the biliary tract carcinoma: results of a project study for biliary surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2020;27:571-80. [PMID: 32510820 DOI: 10.1002/jhbp.776] [Reference Citation Analysis]
37 Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, Sakabe R, Kobayashi H, Sueda T. Is para-aortic lymph node metastasis a contraindication for radical resection in biliary carcinoma? World J Surg. 2011;35:1085-1093. [PMID: 21400012 DOI: 10.1007/s00268-011-1036-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
38 Yu H, Wu SD, Chen DX, Zhu G. Laparoscopic resection of Bismuth type I and II hilar cholangiocarcinoma: an audit of 14 cases from two institutions. Dig Surg. 2011;28:44-49. [PMID: 21293131 DOI: 10.1159/000322398] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
39 Liang L, Li C, Jia HD, Diao YK, Xing H, Pawlik TM, Lau WY, Shen F, Huang DS, Zhang CW, Yang T. Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies. Ther Adv Gastrointest Endosc 2021;14:2631774521993065. [PMID: 33629062 DOI: 10.1177/2631774521993065] [Reference Citation Analysis]
40 Soares KC, Jarnagin WR. The Landmark Series: Hilar Cholangiocarcinoma. Ann Surg Oncol 2021;28:4158-70. [PMID: 33829358 DOI: 10.1245/s10434-021-09871-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 DeOliveira ML, Kambakamba P, Clavien PA. Advances in liver surgery for cholangiocarcinoma. Curr Opin Gastroenterol. 2013;29:293-298. [PMID: 23563982 DOI: 10.1097/mog.0b013e3283600a92] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
42 Uesaka K. Left hepatectomy or left trisectionectomy with resection of the caudate lobe and extrahepatic bile duct for hilar cholangiocarcinoma (with video). J Hepatobiliary Pancreat Sci 2012;19:195-202. [PMID: 22076670 DOI: 10.1007/s00534-011-0474-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
43 Chen JY, Cai SW, Liu ZW, Xing XL. Left hepatectomy with caudate lobe resection using the methylene blue staining technique for bismuth IIIb hilar cholangiocarcinoma. Hepatobiliary Surg Nutr 2019;8:674-6. [PMID: 31930006 DOI: 10.21037/hbsn.2019.05.06] [Reference Citation Analysis]
44 Weiss MJ, Cosgrove D, Herman JM, Rastegar N, Kamel I, Pawlik TM. Multimodal treatment strategies for advanced hilar cholangiocarcinoma. Langenbecks Arch Surg. 2014;399:679-692. [PMID: 24962146 DOI: 10.1007/s00423-014-1219-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
45 Lee JH, Hwang DW, Lee SY, Park K, Lee Y. The Proximal Margin of Resected Hilar Cholangiocarcinoma: The Effect of Microscopic Positive Margin on Long-Term Survival. The American Surgeon 2012;78:471-7. [DOI: 10.1177/000313481207800440] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
46 Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, Nagino M. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg. 2012;256:297-305. [PMID: 22750757 DOI: 10.1097/sla.0b013e31826029ca] [Cited by in Crossref: 129] [Cited by in F6Publishing: 37] [Article Influence: 12.9] [Reference Citation Analysis]
47 Yang H, Zhou J, Wei X, Wang F, Zhao H, Li E. Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor. Mol Clin Oncol 2014;2:1069-75. [PMID: 25279199 DOI: 10.3892/mco.2014.377] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
48 de Jong MC, Hong SM, Augustine MM, Goggins MG, Wolfgang CL, Hirose K, Schulick RD, Choti MA, Anders RA, Pawlik TM. Hilar cholangiocarcinoma: tumor depth as a predictor of outcome. Arch Surg. 2011;146:697-703. [PMID: 21690446 DOI: 10.1001/archsurg.2011.122] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
49 Lee SR, Kim HO, Shin JH. The Strategy of Treatment for Mid to Distal Cholangiocarcinoma after Surgical Resection. The American Surgeon 2018;84:820-5. [DOI: 10.1177/000313481808400625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Mei Y, Peng CJ, Li WN, Li XX, Xie WT, Shu DJ, Zhang JG. Surgical treatment of hilar cholangiocarcinoma: New advances. Shijie Huaren Xiaohua Zazhi 2015; 23(18): 2907-2912 [DOI: 10.11569/wcjd.v23.i18.2907] [Reference Citation Analysis]
51 Matsuyama R, Mori R, Ota Y, Homma Y, Kumamoto T, Takeda K, Morioka D, Maegawa J, Endo I. Significance of Vascular Resection and Reconstruction in Surgery for Hilar Cholangiocarcinoma: With Special Reference to Hepatic Arterial Resection and Reconstruction. Ann Surg Oncol 2016;23:475-84. [PMID: 27387681 DOI: 10.1245/s10434-016-5381-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
52 Nanashima A, Imamura N, Hiyoshi M, Yano K, Hamada T, Chiyotanda T, Nagatomo K, Hamada R, Ito H. A successfully resected case of left trisectionectomy with arterio-portal combined resection for advanced cholangiocarcinoma. Int J Surg Case Rep 2018;53:90-5. [PMID: 30390491 DOI: 10.1016/j.ijscr.2018.10.036] [Reference Citation Analysis]
53 Aoki S, Mizuma M, Takahashi Y, Haji Y, Okada R, Abe T, Karasawa H, Tamai K, Okada T, Morikawa T, Hayashi H, Nakagawa K, Motoi F, Naitoh T, Katayose Y, Unno M. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties. BMC Cancer. 2016;16:854. [PMID: 27821106 DOI: 10.1186/s12885-016-2919-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
54 Higuchi R, Ota T, Yazawa T, Kajiyama H, Araida T, Furukawa T, Yoshikawa T, Takasaki K, Yamamoto M. Improved surgical outcomes for hilar cholangiocarcinoma: changes in surgical procedures and related outcomes based on 40 years of experience at a single institution. Surg Today 2016;46:74-83. [DOI: 10.1007/s00595-015-1119-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
55 Titapun A, Luvira V, Srisuk T, Jareanrat A, Thanasukarn V, Thanee M, Sa-Ngiamwibool P, Padthaisong S, Duangkumpha K, Suksawat M, Loilome W, Sithithaworn P, Techasen A, Thinkhamrop B, Dzienny A, Caglayan A, Park D, Mahmud S, Khuntikeo N. High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection. Int J Gen Med 2021;14:2191-204. [PMID: 34103974 DOI: 10.2147/IJGM.S306339] [Reference Citation Analysis]
56 Watanabe Y, Kuboki S, Shimizu H, Ohtsuka M, Yoshitomi H, Furukawa K, Miyazaki M. A New Proposal of Criteria for the Future Remnant Liver Volume in Older Patients Undergoing Major Hepatectomy for Biliary Tract Cancer. Ann Surg. 2018;267:338-345. [PMID: 27849659 DOI: 10.1097/sla.0000000000002080] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
57 Sano T, Shimizu Y, Senda Y, Komori K, Ito S, Abe T, Kinoshita T, Nimura Y. Isolated caudate lobectomy with pancreatoduodenectomy for a bile duct cancer. Langenbecks Arch Surg 2013;398:1145-50. [PMID: 24026222 DOI: 10.1007/s00423-013-1110-5] [Reference Citation Analysis]
58 Nagino M. Perihilar cholangiocarcinoma: a surgeon’s viewpoint on current topics. J Gastroenterol. 2012;47:1165-1176. [PMID: 22847554 DOI: 10.1007/s00535-012-0628-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
59 Chaudhary RJ, Higuchi R, Nagino M, Unno M, Ohtsuka M, Endo I, Hirano S, Uesaka K, Hasegawa K, Wakai T, Uemoto S, Yamamoto M. Survey of preoperative management protocol for perihilar cholangiocarcinoma at 10 Japanese high-volume centers with a combined experience of 2,778 cases. J Hepatobiliary Pancreat Sci 2019;26:490-502. [PMID: 31520452 DOI: 10.1002/jhbp.668] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
60 Tang Z, Yang Y, Zhao Z, Wei K, Meng W, Li X. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e11999. [PMID: 30142840 DOI: 10.1097/MD.0000000000011999] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]